Medical Imaging Corporation (6637) Fair Value & Analysis
Healthcare · TW · Market cap 1.7B TWD
Fair value as of: Jul 23, 2026
From 17 valuation models · updated 18 days ago
Share price −6.1% over the past month.
Below-average quality, screening 113% undervalued on our models.
What matters now
- The large discount to fair value meets weak quality (35/100). That raises the risk this is a value trap rather than a bargain.
- The model range is unusually wide (59.52 TWD to 165.81 TWD). The outcome hinges heavily on assumptions, so read the point estimate with caution.
Price vs Fair Value (5 years)
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Jul 23, 2026.
How to read this chart
60‑month range 31.39 TWD – 136.58 TWD · fair‑value band 59.52 TWD – 165.81 TWD · the 62.00 TWD price screens below the 132.01 TWD fair value. Dashed = 300-day average. As of Jul 23, 2026.
Analysis
Medical Imaging Corporation (6637) currently trades at 62.00 TWD, while our model-based Fair Value estimate is 132.01 TWD, implying the stock looks roughly 112.9% undervalued today. The Quality Score stands at 35/100 (below-average quality), in the Healthcare sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high), always confirm before acting.
Over the trailing twelve months, Medical Imaging Corporation generated revenue of 1.2B TWD at a net margin of 14.7%. Revenue grew 51.3% year over year. It earns a return on equity of 17.4%. Net debt stands at 85.9M TWD. Fundamentals as of Jul 23, 2026
Our scenario range runs from 59.52 TWD (bear case) to 165.81 TWD (bull case); at 62.00 TWD, the current price sits within that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 43% below its 52-week high, currently below its 200-day average. For context, the median of 10 Healthcare peers we cover trades at 2% fair-value upside, at 113%, 6637 screens cheaper than that median.
Fair Value models
Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.
All 17 models by family
Widest divergence: Growth Earnings (289.75 TWD) versus Asset-Based (27.99 TWD). Highest evidence: Residual Income (76).
Notify me when 6637 reaches fair value
Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click.
Key figures & financial health
More key figures
Figures from reported company fundamentals · as of Jul 23, 2026. TTM = trailing twelve months.
Quality Score breakdown
Of which business quality 37 · Market factors (momentum, volatility) 33
Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.
About the company
Medical Imaging Corporation offers imaging hospital equipment leasing and maintenance services in China. The company's products include ultrasound sonography, bone densitometer, emergency rooms and intensive isolation wards, and radiation protection lead plates.
Full company description
Medical Imaging Corporation offers imaging hospital equipment leasing and maintenance services in China. The company's products include ultrasound sonography, bone densitometer, emergency rooms and intensive isolation wards, and radiation protection lead plates. It also distributes medical equipment and drugs; and engages in the wholesale and retail of pharmaceuticals and medical equipment, as well as international trade and management consulting activities. The company was founded in 1992 and is based in Taipei, Taiwan.
Company description, as reported by the company or data provider.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
Medical Imaging Corporation reported revenue of 1.2B TWD in FY2025 versus 604M TWD in FY2021, a compound +17.8%/yr. Reported net income was 186M TWD in FY2025, compounding +24.7%/yr from FY2021.
Watch 6637: get an alert when its fair value changes →
Peer Group
Medical Distribution · 81 stocks
How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.
Valuation Multiples vs Medical Distribution median · lower = cheaper
Snowflake
Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.
Similar stocks
10 more Medical Distribution stocks, each showing price versus our Fair Value estimate (as of Jul 23, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| McKesson Corporation MCK | $805.96 | $819.31 | +2% |
| Cencora, Inc COR | $303.44 | $175.74 | -42% |
| Cardinal Health, Inc CAH | $224.94 | $141.77 | -37% |
| Henry Schein, Inc HSIC | $87.82 | $74.67 | -15% |
| Shanghai Pharmaceuticals Holding 601607 | ¥16.70 | ¥33.96 | +103% |
| Sinopharm Group 1099 | HK$16.74 | HK$61.33 | +266% |
| Galenica AG GALE | CHF 87.05 | CHF 61.79 | -29% |
| Guangzhou Baiyunshan Pharmaceutical Holdings 600332 | ¥21.50 | ¥28.65 | +33% |
| Jointown Pharmaceutical Group 600998 | ¥4.99 | ¥9.84 | +97% |
| Asker Healthcare Group ASKER | kr 79.45 | kr 25.69 | -68% |
Compare Medical Imaging Corporation with another stock
Price, fair value, quality and upside side by side.
Explore undervalued stocks
More undervalued Healthcare stocks →
Frequently asked questions
Is Medical Imaging Corporation (6637) overvalued or undervalued?
What is the fair value of 6637?
What is the quality score of 6637?
What is the revenue of Medical Imaging Corporation (6637)?
What is the net profit margin of 6637?
Does Medical Imaging Corporation pay a dividend?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.
Track Medical Imaging Corporation and try Pro for 14 days
One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.
Zero risk: nothing is ever charged. After 14 days you decide whether to stay.